Page last updated: 2024-11-08

manganese(iii)tetraphenylporphine sulfonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

manganese(III)tetraphenylporphine sulfonate: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5486694
MeSH IDM0158900

Synonyms (8)

Synonym
manganese(iii)tetraphenylporphine sulfonate
mn(iii)tpps4
manganese(iii)-tetrakis(4-sulfonatophenyl)porphyrin
manganate(3-), ((4,4',4'',4'''-(21h,23h-porphine-5,10,15,20-tetrayl)tetrakis(benzenesulfonato))(6-)-n21,n22,n23,n24)-, (sp-4-1)-
mn-tpps4
88992-32-9
mn(iii)mesotetraphenylporphine sulfonate
manganese(3+);4-[10,15,20-tris(4-sulfonatophenyl)porphyrin-22,23-diid-5-yl]benzenesulfonate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.26)18.7374
1990's16 (84.21)18.2507
2000's1 (5.26)29.6817
2010's1 (5.26)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]